Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I...

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• Cytotoxic CD4 T cell effectors (ThCTLs) are vital for clearing virus-infected cells expressing MHC class II.
• Understanding the differentiation pathways of CD4 T cells during viral infections is crucial for developing effective immunotherapies.

Purpose of the Study:

• To identify the key factors driving the differentiation of non-cytotoxic CD4 effectors into lung tissue-resident ThCTL effectors during influenza A virus infection.
• To elucidate the spatial, temporal, and cellular requirements for optimal ThCTL generation in the context of viral persistence.

Main Methods:

• Investigated the role of antigen recognition by CD4 effectors on antigen-presenting cells (APCs) within the lungs.
• Assessed the necessity of CD28 co-stimulation for ThCTL development.
• Examined the impact of infection-induced signals, specifically type I interferon (IFN) and interleukin-15 (IL-15), on CD4 effector differentiation.

Main Results:

• CD4 effectors require re-cognition of cognate antigen on lung APCs (dendritic cells or B cells) for ThCTL differentiation.
• CD28 co-stimulation is not essential for optimal ThCTL generation.
• Infection-induced type I IFN signaling promotes IL-15 production, which is critical for CD4 effector differentiation into ThCTLs.

Conclusions:

• The differentiation of ThCTLs is regulated by multiple factors including antigen presentation, APC type, and infection-derived cytokines like IL-15.
• These regulatory mechanisms prevent excessive ThCTL responses post-viral clearance while promoting their development during persistent infections.
• Continuing influenza infection promotes the development of diverse CD4 effector subsets through distinct pathways, contributing to a more robust immune response.